| Autor: |
Martorana D; Unit of Medical Genetics and CoreLab, Research Common Center, University-Hospital of Parma, Parma 43126, Italy. Electronic address: dmartorana@ao.pr.it., Bajema IM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, Netherlands. |
| Jazyk: |
angličtina |
| Zdroj: |
The Lancet. Rheumatology [Lancet Rheumatol] 2024 Jun; Vol. 6 (6), pp. e333-e335. Date of Electronic Publication: 2024 May 08. |
| DOI: |
10.1016/S2665-9913(24)00091-2 |
| Abstrakt: |
Competing Interests: DM declares no competing interests. IMB reports consulting fees from Boehringer Ingelheim, GSK, Novartis, Aurinia, Vifor, Catalyst Science, Toleranzia, Hansa, and Alentis; payment for nephropathology courses organised by her company; and participation on an advisory board for Vifor and Novartis. IMB is also the owner of BiPath, a company registered at the Dutch Chamber of Commerce. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
